Lv1
30 积分 2023-11-14 加入
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study
1个月前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
3个月前
已完结
NKT cells—a generalist in disease treatment and a new key to unlock immunotherapy
3个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
3个月前
已完结
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
3个月前
已完结
Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy
3个月前
已完结
CAR-T therapy in solid tumors
3个月前
已完结
Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
3个月前
已完结
Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
3个月前
已完结
A Nomogram for Predicting Progression-Free Survival in Primary Extramedullary Multiple Myeloma Using Routine Laboratory Variables
5个月前
已完结
皖公网安备34019202002308
